Author Archive: BIOtechNOW Editor

Jim Greenwood Talks 21st Century Cures with Chairman Fred Upton

21st-Century-Cures--Free

Recently, BIO CEO and President Jim Greenwood sat down with House Energy and Commerce Chairman Fred Upton (R-MI) to talk about the Committee’s 21st Century Cures initiative, which seeks to “determine what steps we can take to ensure we are taking full advantage of the advances this country has made in science” to speed and improve drug discovery, development and delivery.  This is a bipartisan effort Chairman Upton and the committee are undertaking with the Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , ,

Is Regulatory Transformation for Alzheimer’s Therapies Needed?

Mary Canady

BIO 2014′s  session titled ” Regulatory Transformation: As Alzheimer’s Disease Science, Research and Advocacy Move Toward Earlier Detection and Intervention, How Will Researchers Adapt to this Evolution?” discussed progress and challenges facing researchers and the collaborative efforts between the Food and Drug Administration (FDA) and patient advocacy groups to help them find a cure. The discussion centered on recent FDA Draft Guidance for Early Stage Alzheimer’s Disease Drug Development which allows for an accelerated approval Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Excerpts From Top Ten Current Science Trends Talk

biotech Primer

For the opening day of BIO 2014, BioTech Primer delivered a talk on the Top 10 Current Science Trends, Issues, & Advances.  Three of the technologies covered are highlighted below. Genome Editing: We often refer to a person’s genome – his complete set of genes – as a blueprint for life. But sometimes there are errors in this blueprint. Wouldn’t it be great if we could edit the blueprint and correct these errors? We might Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Access to Big Data

Emerging-Companies115x76

Aquiring information rapidly and reliably reduces costs and advances discovery Sixty years ago, when James Watson and Francis Crick elucidated and published their seminal work on the double helical nature of DNA, they could hardly have imagined the explosion of information about cellular activities and disease pathways happening today. With this explosion, the challenge for scientific database producers is to curate and process the published literature, small molecules, proteins, sequences and numeric data in ways Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Industry-Disease Foundation Partnerships Thrive on Communication & Transparency

Attendees

Disease foundations are playing an increasingly important role in advancing research and helping to bring new treatments to market. Their unique expertise in specific disease areas, along with their keen understanding of patient needs and access to clinical thought leaders and patients, can enhance and accelerate the clinical development of new treatments. At a 2014 BIO International Convention Breakout Session, session moderator Gail Maderis, President and CEO of BayBio, opened with some key statistics about Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,